1121 related articles for article (PubMed ID: 19620302)
1. Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation.
Poisson C; Rollin S; Véronneau S; Bousquet SM; Larrivée JF; Le Gouill C; Boulay G; Stankova J; Rola-Pleszczynski M
J Immunol; 2009 Aug; 183(4):2747-57. PubMed ID: 19620302
[TBL] [Abstract][Full Text] [Related]
2. Caveolae as potential mediators of MCH-signaling pathways.
Cook LB; Delorme-Axford EB; Robinson K
Biochem Biophys Res Commun; 2008 Oct; 375(4):592-5. PubMed ID: 18722347
[TBL] [Abstract][Full Text] [Related]
3. Implications of lipid raft disintegration: enhanced anti-inflammatory macrophage phenotype.
Cuschieri J
Surgery; 2004 Aug; 136(2):169-75. PubMed ID: 15300176
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains.
Patel HH; Murray F; Insel PA
Handb Exp Pharmacol; 2008; (186):167-84. PubMed ID: 18491052
[TBL] [Abstract][Full Text] [Related]
5. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
6. Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-kappa B kinase in human U87 astrocytoma cells.
Kam AY; Liu AM; Wong YH
J Neurochem; 2007 Nov; 103(4):1553-66. PubMed ID: 17727628
[TBL] [Abstract][Full Text] [Related]
7. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
Quest AF; Leyton L; Párraga M
Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase.
Vihanto MM; Vindis C; Djonov V; Cerretti DP; Huynh-Do U
J Cell Sci; 2006 Jun; 119(Pt 11):2299-309. PubMed ID: 16723736
[TBL] [Abstract][Full Text] [Related]
9. Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes.
Insel PA; Head BP; Ostrom RS; Patel HH; Swaney JS; Tang CM; Roth DM
Ann N Y Acad Sci; 2005 Jun; 1047():166-72. PubMed ID: 16093494
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 and lipid rafts in confluent BeWo trophoblasts: evidence for Rock-1 association with caveolin-1.
Rashid-Doubell F; Tannetta D; Redman CW; Sargent IL; Boyd CA; Linton EA
Placenta; 2007; 28(2-3):139-51. PubMed ID: 16480767
[TBL] [Abstract][Full Text] [Related]
11. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.
Radeva G; Perabo J; Sharom FJ
FEBS J; 2005 Oct; 272(19):4924-37. PubMed ID: 16176266
[TBL] [Abstract][Full Text] [Related]
12. Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation.
Liu YT; Song L; Templeton DM
J Cell Physiol; 2007 Apr; 211(1):205-12. PubMed ID: 17226785
[TBL] [Abstract][Full Text] [Related]
13. Reggie-1 and reggie-2 localize in non-caveolar rafts in epithelial cells: cellular localization is not dependent on the expression of caveolin proteins.
Fernow I; Icking A; Tikkanen R
Eur J Cell Biol; 2007 Jun; 86(6):345-52. PubMed ID: 17482312
[TBL] [Abstract][Full Text] [Related]
14. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor.
Gilad LA; Schwartz B
J Mol Endocrinol; 2007 Jun; 38(6):603-18. PubMed ID: 17556531
[TBL] [Abstract][Full Text] [Related]
15. Serine 23 and 36 phosphorylation of caveolin-2 is differentially regulated by targeting to lipid raft/caveolae and in mitotic endothelial cells.
Sowa G; Xie L; Xu L; Sessa WC
Biochemistry; 2008 Jan; 47(1):101-11. PubMed ID: 18081315
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae.
Hong S; Huo H; Xu J; Liao K
Cell Death Differ; 2004 Jul; 11(7):714-23. PubMed ID: 15002041
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
18. Sterol carrier protein-2 selectively alters lipid composition and cholesterol dynamics of caveolae/lipid raft vs nonraft domains in L-cell fibroblast plasma membranes.
Atshaves BP; Gallegos AM; McIntosh AL; Kier AB; Schroeder F
Biochemistry; 2003 Dec; 42(49):14583-98. PubMed ID: 14661971
[TBL] [Abstract][Full Text] [Related]
19. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
